HSBC Launches TradePay for Import Duties Solution for US Clients

 HSBC today announced the launch of HSBC TradePay for Import Duties, a targeted financing solution for US clients which simplifies the payment of import duties while optimizing working capital for businesses.

Many corporates are currently facing changing working capital needs and increased upfront commitments. By settling payments of import duties directly and frictionlessly through HSBC TradePay, businesses can simultaneously access credit and complete payments, leading to more efficient settlement times and better visibility over cash flows.

The solution is flexible and ensures import duty payments are made directly by HSBC, either through pre-agreed credit terms with brokers or direct ACH credits.

Vivek Ramachandran, Head of Global Trade Solutions at HSBC said:

"Clients’ working capital needs are evolving – and we’re responding swiftly with solutions that deliver the most value to them. By settling import duties directly and frictionlessly through HSBC TradePay, our US clients have more visibility and control over their working capital at the time they need it most. As the world’s leading trade bank, we’re committed to supporting global businesses as a strategic partner and innovative problem solver, helping our clients navigate the complexities of global trade."

The HSBC TradePay platform utilizes innovative, digital solutions to help facilitate the transition away from paper-based operations, integrating financing and payments into one single journey.

Since its initial launch in 2023, HSBC TradePay has made $2.3bn of trade finance available across the globe.

https://finance.yahoo.com/news/hsbc-launches-tradepay-import-duties-120000643.html

Airbus Backs European Tariffs on Boeing If Talks With US Fail

 

Europe should impose reciprocal measures on Boeing Co. if negotiations fail to lift recent US tariffs hurting the aerospace industry, according to Airbus SE Chief Executive Officer Guillaume Faury.

“Europe is in negotiations, and if these negotiations do not lead to a positive outcome, I imagine that — and this is what we hope for — reciprocal tariffs on aircrafts will be imposed to force a higher level of negotiation and return to the 1979 agreement,” he told reporters at an event in Paris. “This would be good for both the US and European industries.”

https://www.bloomberg.com/news/articles/2025-05-06/airbus-backs-european-tariffs-on-boeing-if-talks-with-us-fail

Ford reportedly hikes prices on Mexico-produced models following US tariffs

 Ford Motor (NYSE:F) has raised prices on three of its models produced in Mexico, effective from May 2, according to a Reuters report on Wednesday. This move makes Ford one of the first significant automakers to adjust its sticker prices in response to the tariffs introduced by U.S. President Donald Trump.

The models affected by this price increase include the Mustang Mach-E electric SUV, the Maverick pickup, and the Bronco Sport. The price hike for these vehicles can reach up to $2,000 on some models.

https://www.investing.com/news/stock-market-news/ford-reportedly-hikes-prices-on-mexicoproduced-models-following-us-tariffs-93CH-4028394

Disney to open theme park in the Middle East

 Walt Disney has announced plans to open its first theme park in the Middle East.

The resort, which will be in the United Arab Emirates on Abu Dhabi's Yas Island, is a collaboration between Walt Disney and local leisure and entertainment company Miral.

Disney already has six theme parks spanning North America, Europe and Asia. Its most recent opening was in 2016 in Shanghai.

Miral is responsible for the development of Yas Island as a tourist destination and already operates SeaWorld and Warner Bros World where it is developing a Harry Potter-themed park.

In a statement announcing the new facility, Disney said the UAE was located within a four-hour flight of one-third of the world's population, making it a "significant gateway for tourism".

It added that 120 million passengers travel through Abu Dhabi and Dubai every year, making the Emirates the biggest global airline hub in the world.

Disney chief executive Robert Iger described the plans for the new park as a "thrilling" moment for the company and said Disneyland Abu Dhabi would be "authentically Disney and distinctly Emirati".

The 25 sq km Yas Island is 20 minutes from downtown Abu Dhabi and 50 minutes from Dubai.

Miral's boss Mohamed Abdalla Al Zaabi said bringing a Disney theme park resort to the area marked a "milestone in our journey to further advance the island's position as a global destination for exceptional entertainment and leisure".

He said the development would "support sustained economic growth in Abu Dhabi and beyond".

https://www.bbc.com/news/articles/cdrgr2zzv00o

White House Chief Of Staff Clarifies "Due Process" For Deporting Illegals In 4 Words...

 by Steve Watson via Modernity.news,

White House Deputy Chief of Staff Stephen Miller has shared a succinct definition of the “due process” leftists are continually referencing regarding the issue of deportation of illegal aliens.

It’s not complicated.

The correct process for illegal aliens:

Are you here illegally?

Deport.

— Stephen Miller (@StephenM) May 6, 2025

That about covers it.

I fully agree with this due process.

Should be super simple. Super fast. Easy to understand and prove.

Who could be against this?

— Matt Van Swol (@matt_vanswol) May 6, 2025

Exactly. Why is this difficult for so many people.

— Alisha Nasse (@AlishaNasse) May 6, 2025

Simple yes or no solution.
Yes=go
No=prove and stay.

Yes, goes right back home.

No trial needed to get in , no trial needed to leave.

— Priest. (@lob679) May 6, 2025

Why is this even controversial? Every other country on Earth does it.

— Voted for this 🇺🇸 (@PatriotChris__) May 6, 2025

Well, British people might argue with that point, but you catch the drift.

Fox News contributor Mollie Hemingway hit the nail on the head when discussing the “due process” Democrats are so eager to bring up over and over.

“It’s hard to take people in good faith when they’re talking about due process and rule of law, when they didn’t care at all about due process and rule of law when the border was completely open to bring in tens of millions of illegal immigrants,” she urged.

“That’s why there’s this nationwide injunction case before the Supreme Court is so important,” Hemingway continued, adding

“You had an election. Donald Trump was very clear that he wanted to shut down the border, and he wanted to deport people who were here illegally. And people voted for that.”

“And now you have all of these rogue lower level judges who are, frankly, embarrassing the Supreme Court with these temporary restraining orders and nationwide injunctions, where they’re saying, we don’t care who won the election, we’re going to pretend that Joe Biden is still president or that Kamala Harris won the presidency,” Hemingway further emphasised.

🚨@MZHemingway: Rogue judges “don't care who won the election” — want to implement Democrat immigration policy from the bench:

“It's hard to take people in good faith when they're talking about due process and rule of law, when they didn't care at all about due process and rule… pic.twitter.com/ts3PWQAONx

— Western Lensman (@WesternLensman) May 5, 2025

This "due process" narrative is a joke. They don't have to have due process. And other presidents deported people too. If it wasn't an issue then it can't be now. Because it's Trump.

— Garrett Phipps (@Phipps31) May 5, 2025

Trump is the only president that can't deport illegals.

— Schwarby1958 (@schwarby1958) May 6, 2025

https://www.zerohedge.com/political/white-house-chief-staff-clarifies-due-process-deporting-illegals-4-words

FDA ramps up unannounced inspections of foreign facilities

 The FDA has said it will expand unannounced inspections of overseas manufacturing facilities supplying medicine and other medical products to the US.

The aim is to make sure that foreign companies "receive the same level of regulatory oversight and scrutiny as domestic companies," according to the regulator, which pointed out that domestic inspections are generally unannounced but those for overseas are often flagged in advance.

There was no indication from the FDA about how many inspections it intends to carry out, or how its capacity to conduct them may be affected by recent staffing reductions at the agency.

At the same time as the policy was announced, Associate Commissioner Michael Rogers – head of the Office of Inspections and Investigations (OII), set up last October – said he was stepping down from the role amid the staffing reductions.

FDA Commissioner Martin Makary has been vocal about his view that overseas manufacturers are held to a different standard than their counterparts within the US.

The FDA conducts approximately 12,000 domestic inspections and 3,000 foreign inspections each year in more than 90 countries, but – despite advanced warnings – finds serious deficiencies more than twice as often as during domestic inspections, it said.

"For too long, foreign companies have enjoyed a double standard – given advanced notice before facility inspections, while American manufacturers are held to rigorous standards with no such warning," said Makary in a statement.

"That ends today," he added. "This is a key step for the FDA as part of a broader strategy to get foreign inspections back on track."

Along with more inspections, the plan is to change policies and practices so that, for example, FDA investigators have to refuse assistance from the companies they regulate, including "lodging and transportation arrangements."

The announcement came hard on the heels of an executive order from President Donald Trump instructing the FDA to identify ways in which it can reduce red tape so that new manufacturing facilities can be set up more quickly in the US.

It also orders the regulator to disclose the annual number of inspections that the FDA conducts on foreign facilities, publicly disclose those that do not comply, and tighten up its oversight of overseas ingredients producers.

The order is part of a broader effort by the federal government to ensure that medicines intended for consumption in the US are also made there, and follows announcements of new facility projects by various big pharma groups, including AbbVie, Eli Lilly, Johnson & Johnson, Novartis, and Roche.

https://pharmaphorum.com/news/fda-ramps-unannounced-inspections-foreign-facilities

UK trumpets a trade deal with India - but pharma isn't happy

 Various industry bodies have welcomed news of a trade deal between the UK and India, but the Association of the British Pharmaceutical Industry (ABPI) is not among them.

The deal has been held up as a way to boost the economies of both nations at a time when tariffs imposed by the US are wreaking havoc with international trade, with UK Prime Minister Keir Starmer saying it would boost British exports to India by an additional £25.5 billion over its 2024 level of $42.6 billion.

The ABPI has deep reservations, however, saying in a statement released this morning that the agreement does not address "longstanding industry concerns about intellectual property protections for UK life science innovators within the Indian market."

In particular, the trade organisation is concerned about regulatory data protection (RDP), referring to the extensive data from preclinical and clinical trials to demonstrate the quality, efficacy and safety of a new medicine.

"As one of the UK's largest exporting sectors, it's disappointing that this deal seemingly won't support the UK's growth ambitions for pharmaceuticals," said Richard Torbett, the ABPI's chief executive.

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's figures. India is a massive supplier of generic medicines for global markets, with ABPI figures suggesting Indian producers imported almost $657 million in drugs in the year to the end of the third quarter of 2024.

When the bilateral trade talks were first announced in 2022, the ABPI said a deal could be one of the most important that Britain could strike for life sciences.

"Robust intellectual property protections are fundamental for the innovation our companies deliver, but we believe an opportunity has been missed by the UK to demonstrate a commitment to high IP standards for our sector in this agreement," continued Torbett.

"We urge the government to use ongoing negotiations with other key trading partners, including the EU, US, and Switzerland, to deliver agreements that better support Britain's pharmaceutical industry," he added.

The UK government highlighted lower tariffs on imports of clothing, cars, food, and jewellery from India, along with lower levies on exports of spirits, aerospace products, electrical machinery, food, cosmetics, higher value cars, and medical devices.

The deal, which has been three years in negotiation, means that "UK businesses gain a competitive edge over international competitors when entering India's enormous market as it gets even bigger, forecasted to become the third largest global economy within three years," it said.

https://pharmaphorum.com/news/uk-trumpets-trade-deal-india-pharma-isnt-happy